AC regimen

DRUG3 trials

Sponsors

Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, UNICANCER

Conditions

Breast CancerCognitive/Functional EffectsDepressionMalnutritionPsychosocial Effects of Cancer and Its Treatment

Phase 2

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

CompletedNCT00424203

UNICANCERBreast Cancer, Cognitive/Functional Effects, Depression +2

Start: 2006-01-31End: 2011-11-30Updated: 2013-09-04

Phase 3

Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

CompletedNCT00041119

Alliance for Clinical Trials in OncologyBreast Cancer

Start: 2002-05-31End: 2014-06-30Updated: 2017-05-18

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Active, not recruitingNCT00070564

SWOG Cancer Research NetworkBreast Cancer

Start: 2003-11-01End: 2027-01-01Updated: 2026-08-28

Related Papers

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.

2024-05-30

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221

Journal of the National Comprehensive Cancer Network2023-11-0122 citations

Abstract 494: Role of age, BMI, and tumor subtype in racial/ethnic disparities in breast cancer survival: A pooled analysis of four Alliance adjuvant clinical trials

Cancer Research2022-06-15

Vitamin D insufficiency as a peripheral neuropathy risk factor in white and black patients in SWOG 0221.

Journal of Clinical Oncology2022-06-012 citations

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)

Breast Cancer Research2018-11-2822 citations

Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

The Oncologist2018-11-0829 citations

SWOG S0221 updated: Randomized comparison of chemotherapy schedules in breast cancer adjuvant therapy.

Journal of Clinical Oncology2017-05-20

Abstract 3413: Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221

Cancer Research2016-07-15

Outcome of male patients and black patients enrolled in S0221, an intergroup chemotherapy study.

Journal of Clinical Oncology2014-05-20

S0221: Comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer.

Journal of Clinical Oncology2013-06-2011 citations